Search results
Results From The WOW.Com Content Network
During Athersys' (ATHX) Q4 conference call, investor focus will be on the company's progress with its investigational MultiStem cell therapy to treat various indications.
Investors need to pay close attention to Athersys (ATHX) stock based on the movements in the options market lately.
While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.
List of major stock exchanges. This is a list of major stock exchanges. Those futures exchanges that also offer trading in securities besides trading in futures contracts may be listed both here and in the list of futures exchanges . There are twenty one stock exchanges in the world that have a market capitalization of over US$1 trillion each.
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
Athersys (ATHX) gains on encouraging results from its exploratory study on the intravenous administration of MultiStem cell therapy to treat patients suffering from ARDS.